On December 22, 2025, in Florham Park, New Jersey, Celularity Inc. (Nasdaq: CELU), a company specializing in regenerative and cellular medicine for age-related and degenerative diseases, revealed the completion of its recent financial deals with Philip A. Barach, the ex-president and co-founder of DoubleLine Capital LP.